860
Views
1
CrossRef citations to date
0
Altmetric
Research Article

The effect of Hypericum perforatum on isolated rat aorta

, , , &
Pages 879-883 | Received 26 Oct 2010, Accepted 30 Dec 2010, Published online: 18 May 2011

References

  • Albert D, Zündorf I, Dingermann T, Müller WE, Steinhilber D, Werz O. (2002). Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol, 64, 1767–1775.
  • Apaydin S, Goldeli E, Karamenderes C, Meral G, Zeybek U, Tuglular I. (2001). The inhibitory effect of Hypericum triquetrifolium Turra. Extract on rat aortic smooth muscle contraction. T Klin Med Res, 19, 24–30.
  • Capasso R, Borrelli F, Montanaro V, Altieri V, Capasso F, Izzo AA. (2005). Effects of the antidepressant St. John’s wort (Hypericum perforatum) on rat and human vas deferens contractility. J Urol, 173, 2194–2197.
  • Cirak C, Bertoli A, Pistelli L, Seyis F. (2010). Essential oil composition and variability of Hypericum perforatum from wild populations of northern Turkey. Pharm Biol, 48, 906–914.
  • De Paola R, Muià C, Mazzon E, Genovese T, Crisafulli C, Menegazzi M, Caputi AP, Suzuki H, Cuzzocrea S. (2005). Effects of Hypericum perforatum extract in a rat model of ischemia and reperfusion injury. Shock, 24, 255–263.
  • Demirci B, McKeown PP, Bayraktutan U. (2005). Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its blood pressure-lowering effects. J Hypertens, 23, 2219–2227.
  • Demirci B, McKeown PP, Dvm UB. (2008). The bimodal regulation of vascular function by superoxide anion: Role of endothelium. BMB Rep, 41, 223–229.
  • Dost T, Ozkayran H, Gokalp F, Yenisey C, Birincioglu M. (2009). The effect of Hypericum perforatum (St. John’s Wort) on experimental colitis in rat. Dig Dis Sci, 54, 1214–1221.
  • Fronza M, Heinzmann B, Hamburger M, Laufer S, Merfort I. (2009). Determination of the wound healing effect of Calendula extracts using the scratch assay with 3T3 fibroblasts. J Ethnopharmacol, 126, 463–467.
  • Genovese T, Mazzon E, Di Paola R, Muià C, Crisafulli C, Menegazzi M, Malleo G, Suzuki H, Cuzzocrea S. (2006a). Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock, 25, 161–167.
  • Genovese T, Mazzon E, Menegazzi M, Di Paola R, Muià C, Crisafulli C, Bramanti P, Suzuki H, Cuzzocrea S. (2006b). Neuroprotection and enhanced recovery with Hypericum perforatum extract after experimental spinal cord injury in mice. Shock, 25, 608–617.
  • Gilani AH, Khan AU, Subhan F, Khan M. (2005). Antispasmodic and bronchodilator activities of St John’s wort are putatively mediated through dual inhibition of calcium influx and phosphodiesterase. Fundam Clin Pharmacol, 19, 695–705.
  • Guimarães S, Moura D. (2001). Vascular adrenoceptors: An update. Pharmacol Rev, 53, 319–356.
  • Hammer KD, Hillwig ML, Solco AK, Dixon PM, Delate K, Murphy PA, Wurtele ES, Birt DF. (2007). Inhibition of prostaglandin E(2) production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264.7 mouse macrophage cells. J Agric Food Chem, 55, 7323–7331.
  • Hammer KD, Yum MY, Dixon PM, Birt DF. (2010). Identification of JAK-STAT pathways as important for the anti-inflammatory activity of a Hypericum perforatum fraction and bioactive constituents in RAW 264.7 mouse macrophages. Phytochemistry, 71, 716–725.
  • Herman AG, Moncada S. (2005). Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis. Eur Heart J, 26, 1945–1955.
  • Hunt EJ, Lester CE, Lester EA, Tackett RL. (2001). Effect of St. John’s wort on free radical production. Life Sci, 69, 181–190.
  • Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ, Sato K. (1997). Calcium movements, distribution, and functions in smooth muscle. Pharmacol Rev, 49, 157–230.
  • Khan AU, Khan M, Subhan F, Gilani AH. (2009). Antispasmodic, bronchodilator and blood pressure lowering properties of Hypericum oblongifolium–possible mechanism of action. Phytother Res, 24, 1027–1032.
  • Khan AU, Gilani AH, Rehman N. (2011). Pharmacological studies on Hypericum perforatum fractions and constituents. Pharm Biol 49, 46–56.
  • Klabunde RE, Ryan KM, Paxson CE. (2007). Acute hyperglycaemia does not alter coronary vascular function in isolated, perfused rat hearts. Diabetes Obes Metab, 9, 697–705.
  • Kraus B, Wolff H, Elstner EF, Heilmann J. (2010). Hyperforin is a modulator of inducible nitric oxide synthase and phagocytosis in microglia and macrophages. Naunyn Schmiedebergs Arch Pharmacol, 381, 541–553.
  • Lu YH, Du CB, Liu JW, Hong W, Wei DZ. (2004). Neuroprotective effects of Hypericum perforatum on trauma induced by hydrogen peroxide in PC12 cells. Am J Chin Med, 32, 397–405.
  • Melzer R, Fricke U, Hölzl J. (1991). Vasoactive properties of procyanidins from Hypericum perforatum L. in isolated porcine coronary arteries. Arzneimittelforschung, 41, 481–483.
  • Mennini T, Gobbi M. (2004). The antidepressant mechanism of Hypericum perforatum. Life Sci, 75, 1021–1027.
  • Moncada S, Higgs EA. (2006). The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol, 147 (Suppl 1), 193–201.
  • Mukerjee R, Deshmane SL, Darbinian N, Czernik M, Khalili K, Amini S, Sawaya BE. (2008). St. John’s Wort protein, p27SJ, regulates the MCP-1 promoter. Mol Immunol, 45, 4028–4035.
  • Muller WE, Rossol R. (1994). Effects of Hypericum extract on the expression of serotonin receptors. J Geriatr Psychiatry Neurol, 7 (Suppl 1), 63–64.
  • Neary JT, Bu Y. (1999). Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res, 816, 358–363.
  • Neary JT, Whittemore SR, Bu Y, Mehta H, Shi YF (2001): Biochemical mechanisms of action of Hypericum LI 160 in glial and neuronal cells: inhibition of neurotransmitter uptake and stimulation of extracellular signal regulated protein kinase. Pharmacopsychiatry, 34, (Suppl 1), 103–107.
  • Pilkington K, Boshnakova A, Richardson J. (2006). St John’s wort for depression: Time for a different perspective? Complement Ther Med, 14, 268–281.
  • Saad B, Abouatta BS, Basha W, Hmade A, Kmail A, Khasib S, Said O. (2008). Hypericum triquetrifolium-Derived factors downregulate the production levels of LPS-induced nitric oxide and tumor necrosis factor-α in THP-1 cells. Evid Based Complement Alternat Med. http://downloads.hindawi.com/journals/ecam/aip/586470.v1.pdf. Accessed on 26 January 2010.
  • Samadi S, Khadivzadeh T, Emami A, Moosavi NS, Tafaghodi M, Behnam HR. (2010). The effect of Hypericum perforatum on the wound healing and scar of cesarean. J Altern Complement Med, 16, 113–117.
  • Tedeschi E, Menegazzi M, Margotto D, Suzuki H, Förstermann U, Kleinert H. (2003). Anti-inflammatory actions of St. John’s wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1α (STAT-1α) activation. J Pharmacol Exp Ther, 307, 254–261.
  • Tu P, Gibon J, Bouron A. (2010). The TRPC6 channel activator hyperforin induces the release of zinc and calcium from mitochondria. J Neurochem, 112, 204–213.
  • Villar IC, Hobbs AJ, Ahluwalia A. (2008). Sex differences in vascular function: Implication of endothelium-derived hyperpolarizing factor. J Endocrinol, 197, 447–462.
  • Whittle BJ, Moncada S. (1990). The endothelin explosion. A pathophysiological reality or a biological curiosity? Circulation, 81, 2022–2025.
  • Zou Y, Lu Y, Wei D. (2004). Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro. J Agric Food Chem, 52, 5032–5039.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.